CAS 158812-85-2

Omeprazole Sulfone N-Oxide

Description:

Omeprazole Sulfone N-Oxide, with the CAS number 158812-85-2, is a chemical compound derived from omeprazole, a proton pump inhibitor commonly used to treat gastroesophageal reflux disease and other acid-related disorders. This compound is characterized by its sulfone functional group, which contributes to its chemical stability and solubility properties. Omeprazole Sulfone N-Oxide is typically a white to off-white solid, and it exhibits moderate polarity due to the presence of sulfone and nitrogen oxide functionalities. Its molecular structure includes a pyridine ring, which is essential for its biological activity. The compound is known for its role as a metabolite of omeprazole, and it may exhibit different pharmacokinetic and pharmacodynamic properties compared to its parent compound. As with many sulfone derivatives, it may also possess unique interactions with biological systems, influencing its therapeutic efficacy and safety profile. Overall, Omeprazole Sulfone N-Oxide is an important compound in the context of drug metabolism and pharmacology.

Formula: C₁₇H₁₉N₃O₅S

InChI: InChI=1/C17H19N3O5S/c1-10-8-20(21)15(11(2)16(10)25-4)9-26(22,23)17-18-13-6-5-12(24-3)7-14(13)19-17/h5-8H,9H2,1-4H3,(H,18,19)

SMILES: Cc1cn(=O)c(CS(=O)(=O)c2nc3ccc(cc3[nH]2)OC)c(C)c1OC

Synonyms:

• 5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-1-oxido-2-pyridinyl)methyl]sulfonyl]- 1H-benzimidazole
• 5-methoxy-2-{[(4-methoxy-3,5-dimethyl-1-oxidopyridin-2-yl)methyl]sulfonyl}-1H-benzimidazole
• Esomeprazol Impurity 11
• Omeprazole Related Compound I (15 mg)
• Omeprazole sulfone N-oxide / OmeprazoleRelated Compound-I
• 4-Methoxy-2-[[5-Methoxy-1H-enziMidazol-2-l]sulfonl]Methyl]-3,5-diMenthlpridine 1-oxide
• Omeprazole EP impurity I Q: What are the applications of
• Omeprazole EP impurity I Q: What is the CAS Number of
• OMeprazole IMpurity-I (EP)
• Omeprazole sulfonyl nitrogen oxide
• Omeprazole impurity 9/Omeprazole EP Impurity I/Omeprazole Sulfone N-Oxide/5-Methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulphonyl]-1H-benzimidazole N-Oxide
• 4-Methoxy-2-[[(5-methoxy-1H-benzimi
• Omeprazole USP RC I
• Omeprazole EP Impurity I (Omeprazole Sulfone N-Oxide)
• Esomeprazole Impurity Sulfone N-Oxide (Omeprazole EP Impurity I/ Omeprazole Related Compound I/ Omeprazole Sulfone N-Oxide)
• Esomeprazole impurity G
• Omeprazole Sulphoxide
• Esomeprazol impurity G
• Omeprazole EP Impurity I/ Omeprazole Related Compound I (Omeprazole Sulfone N-Oxide/ Esomeprazole Impurity Sulfone N-Oxide)
• Omeprazole EP impurity I
• 1H-BenziMidazole, 6-Methoxy -2-[[(4-Methoxy-3,5-diMethyl-1-oxido-2-pyridinyl)Methyl] sulfonyl]-
• Omeprazole Impurity I
• 4-Methoxy-2-(((6-methoxy-1H-benzo[d]imidazol-2-yl)-sulfonyl)methyl)-3,5-dimethylpyridine 1-oxi
• Omeprazole Sulfone N-Oxide
• Omeprazole USP Related Compound I
• Esomeprazole Impuritie I
• Omeprazole EP Impurity I
• Omeprazole EP impurity I Q: What is the storage condition of
• (4-Methoxy-2-[[(5-methoxy-1H-benzimidazol-2-yl)sulfonyl]methyl]-3,5-dimethylpyridine 1-oxide)
• 6-methoxy-2-[(4-methoxy-3,5-dimethyl-1-oxidopyridin-1-ium-2-yl)methylsulfonyl]-1H-benzimidazole
• Omeprazole Related Compound I (15 mg) (4-Methoxy-2-[[(5-methoxy-1H-benzimidazol-2-yl)sulfonyl]methyl]-3,5-dimethylpyridine 1-oxide)
• OMeprazole Sulphone N-Oxide
• Esomeprazole Impurity 7 CRS
• Omeprazole EP Imp I
• 6-Methoxy-2-[[(4-methoxy-3,5-dimethyl-1-oxido-2-pyridinyl)methyl]sulfonyl]-1H-benzimidazole
• Esomeprazole Impurities533
• 5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulphonyl]-1H-benzimidazole N-oxide
• 6-Methoxy-2-[[(3,5-Dimethyl-4-methoxy-1-oxido-pyridin-2-yl)methyl]sulfonyl]-1H-benzo[d]imidazole
• OMeprazole Related CoMpound I
• Omeprazole EP impurity IQ: What is
• 4-methoxy-2-(((5-methoxy-1H-benzo[d]imidazol-2-yl)sulfonyl)methyl)-3,5-dimethylpyridine 1-oxide
• Esomeprazole Impurity?Sulfone N-Oxide

Omeprazole Related Compound I (4-Methoxy-2-[[(5-methoxy-1H-benzimidazol-2-yl)sulfonyl]methyl]-3,5-dimethylpyridine 1-oxide)

CAS: 158812-85-2

Compounds containing an unfused pyridine ring in the structure, nesoi

Formula: C₁₇H₁₉N₃O₅S

Color and Shape: Light Brown Light Orange Powder

Molecular weight: 377.10454

Ref: 45-1478561

1H-Benzimidazole, 6-methoxy-2-[[(4-methoxy-3,5-dimethyl-1-oxido-2-pyridinyl)methyl]sulfonyl]-

CAS: 158812-85-2

Formula: C₁₇H₁₉N₃O₅S

Purity: 98%

Color and Shape: Solid

Molecular weight: 377.4149

Ref: IN-DA001QWD

Omeprazole sulfone N-Oxide

CAS: 158812-85-2

Omeprazole sulfone N-Oxide

Purity: 95%

Molecular weight: 377.41g/mol

Ref: 54-OR95174

Omeprazole EP Impurity I (Omeprazole USP Related Compound I, Omeprazole Sulfone N-Oxide)

CAS: 158812-85-2

Formula: C₁₇H₁₉N₃O₅S

Color and Shape: White To Off-White Solid

Molecular weight: 377.42

Ref: 4Z-O-0211

4-Methoxy-2-[[(5-methoxy-1H-benzimidazol-2-yl)sulphonyl]methyl]-3,5-dimethylpyridine 1-Oxide (Omeprazole Sulphone N-Oxide)

Controlled Product

CAS: 158812-85-2

Formula: C₁₇H₁₉N₃O₅S

Color and Shape: Neat

Molecular weight: 377.41

Ref: 86-MM0095.16

Omeprazole Impurity 37

CAS: 158812-85-2

Formula: C₁₀H₁₅NO₂

Color and Shape: White To Off-White Solid

Molecular weight: 181.24

Ref: 4Z-O-02117

4-Methoxy-2-(((6-methoxy-1H-benzo[d]imidazol-2-yl)sulfonyl)methyl)-3,5-dimethylpyridine 1-oxide

CAS: 158812-85-2

Purity: 95.0%

Molecular weight: 377.4200134277344

Ref: 10-F237681

Omeprazole EP impurity I

CAS: 158812-85-2

Formula: C₁₇H₁₉N₃O₅S

Molecular weight: 377.41

Ref: ST-EA-CP-O9009

Omeprazole Sulfone N-Oxide

CAS: 158812-85-2

Impurity Omeprazole EP Impurity I
Applications Omeprazole Sulfone N-Oxide (Omeprazole EP Impurity I) is a metabolite of Omeprazole. Impurity I.
References Stevens, C.M., et al.: J. Biol. Chem., 75, 182 (1950), Okamoto, S., et al.: Biochem. Biophys. Res. Commun., 101, 440 (1981)

Formula: C₁₇H₁₉N₃O₅S

Color and Shape: Neat

Molecular weight: 377.41

Ref: TR-O635030

5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulphonyl]-1H-benzimidazole N-oxide

CAS: 158812-85-2

5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulphonyl]-1H-benzimidazole N-oxide is a cyclic sulfoxide that has shown to be a potent inhibitor of gastric acid secretion. It is an important intermediate in the synthesis of esomeprazole magnesium, a proton pump inhibitor used to treat gastroesophageal reflux disease and other gastrointestinal disorders. 5-Methoxy-2-[(4-methoxy 3,5 dimethyl 2 pyridinyl) methyl] sulphonyl]-1H benzimidazole N oxide is also known as (RS)-N-[4-(4′ methoxyphenyl)-3,5 dimethylpyrazol -2 - ylmethyl] methanesulfonamide. This compound has been shown to have a polymorphic form with two different

Formula: C₁₇H₁₉N₃O₅S

Purity: Min. 95%

Color and Shape: Powder

Molecular weight: 377.42 g/mol

Ref: 3D-IM57920